Pathoma Ch 4,5, 16, 17 (Hemostasis, RBC, Breast, CNS) Flashcards
4. Hemostasis and Related D/o 5. RBC D/o 16. Breast 17. CNS
Distinguish primary and secondary hemostasis
Primary hemostasis = formation of weak plt plug
-involves plt, fibrin
Secondary hemostasis = use of coagulation cascade to stabilize plt plug
First thing to happen after BV wall damage
(a) 2 mediators
BV wall damage => Immediate reflexive vasoconstriction
a) Mediated by both neural impulse and endothelin (from endothelial cells
Differentiate receptors/factors used for plt adhesion and plt aggregation
Steps of primary hemostasis (forming weak plt plug): vasoconstriction, plt adhesion, plt degranulation, finally plt aggregation
Plt aggregation = plts bind to subendothelial collagen by binding to vWF via GP1b receptor
Then plt aggregation for plts to clump together mediated by Gp3a2b receptor using fibrinogen
Name the 2 key molecules released by platelet degranulation in primary hemostasis
Plt degranulation (after adhesion, before aggregation) releases
- ADP (from plt dense granules) that promotes exposure of Gp2b3a receptors
- TXA2 (from plt COX) that stimulates plts aggregation
2 places where vWF is made/released from
- Weibel-Palade bodies of endothelial cells (main source)
- this is why ADH (that stimulates Weibel-Palade body release of vWF) is used in the tx of vWD - Alpha-granules of plts
Differentiate the types of bleeding seen in d/o of primary vs. secondary hemostasis
Primary hemostasis = formation of weak platelet plug with plts and fibrin
-d/o => mucosal and skin bleeding = epistaxis, hemoptysis, GI bleed, hematuria, petechiae, purpura
Secondary hemostasis = stabilization of plt plug via coagulation cascade
-d/o (coag factor deficiencies) => deep tissue bleeds in joints and muscles, also rebleeding after surgical procedures (classically wisdom teeth)
Differentiate ecchymoses, purpura, and petechiae
All skin (superficial) bleeds, differentiated by size
Ecchymoses = superficial bleed over 1cm
Purpura: over 3mm
Petechiae: 1-2mm (indicative of thrombocytopenia
Clinical sign that can help distinguish thrombocytopenia from poor quality of plts
Petechiae (1-2mm skin bruises) indicate thrombocytopenia (low number of plts)
-while petechiae are not seen in d/o of plt quality (usually d/o of plt receptors such as Gp1b needed for adhesion, Gp2b3a for aggregation
Bone marrow biopsy expected in ITP
Immune thrombocytopenic purpura (IgG against plts)- see megakaryocyte hyperplasia b/c megakaryocytes trying to compensate for low plts
Name 2 general categories of d/o of primary hemostasis
D/o primary hemostasis = d/o of plts
- Immune thrombocytopenic purpura (ITP) = IgG against plts
- Microangiopathic hemolytic anemia (includes HUS and TTP) = pathologic formation of plt microthrombi in small vessels 2/2 either E. Coli O157:H7 or ADAMTS13 deficiency
Differentiate acute and chronic ITP
Acute ITP seen in children s/p viral illness or vaccination, get self-limited disease
Chronic form in adults (often women of childbearing age, aka same ppl who get AI d/o)
Plt count and PT/PTT values expected in
(a) ITP
(b) HUS
(c) TTP
(a) ITP: reduced plts (2/2 presence of anti-plt IgG so plts destroyed in spleen), PT/PTT normal b/c coagulation cascade (clotting factors) are unaffected
(b) HUS and TTP = microangiopathic hemolytic anemias (meaning pathology of the small HVs that causes hemolytic anemia): reduced plt count (b/c plts used up in microthrombi) and normal PT/PTT
Explain how IVIG aids in the tx of ITP
IVIG = intravenous immunoglobulin
Basically give the spleen another immunoglublin to worry about, so it has a decreased capacity to destroy IgG marked plts
-uesd as very acute/transient therapy during symptomatic bleed
Give 2 mechanisms by which splenectomy treats ITP
ITP = IgG against antibodies
- These antibodies are produced by the spleen
- The spleen is where the plts are destroyed once they become bound to the IgGs
So splenectomy removes both the source of the Ab and the site of plt degradation
HUS vs. TTP
(a) Etiology
(b) MC organ system involved
HUS and TTP are both microangiopathic hemolytic anemias (pathology of small BVs where plt microthrombi are produced causing hemolytic anemia)
HUS = hemolytic uremic syndrome
(a) Etiology = infection w/ E. Coli 0157:H7
(b) MC involves kidney (umm hence uremic in name)
TTP = thrombotic thrombocytopenic purpura
(a) Etiology = deficiency in ADAMTS13 = enzyme needed to cleave vWF into active form => plts abnormal adhere and form microthrombi
(b) MC see CNS abnormalities (thrombi involving vessels of the CNS)
Name the activating substance of the intrinsic and extrinsic pathways of the coagulation cascade
Intrinsic pathway (12 –> 11 –> 9 –> 8 –> X) activates by tissue thromboplastic factor
Extrinsic pathway (7 –> X) activated by subendothelial collagen
Hemophilia A
(a) What is it?
(b) Etiology
(c) Lab findings
Hemophilia A
(a) X-linked recessive deficiency in factor VIII (A ‘eight’)
(b) Etiology: usually X-linked recessive but can be 2/2 de novo mutation
(c) Normal bleeding time (b/c primary hemostasis of weak plt plug is normal, normal plt count), prolonged PTT w/ normal PT
Hemophilia A vs. hemophilia B
Hemophilia A = deficiency in factor VIII
Hemophilia B = deficiency in factor IX (just one back in the cascade): affects same pathway (intrinsic pathway) => both have the same findings of
- prolonged PTT, normal PT
- normal bleeding time b/c plts unaffected
How to differentiate hemophilia A from acquired coagulation factor inhibitor
Hemophilia A = deficiency in factor VIII
Acquired (autoimmune usually) inhibition of factor VIII (ex: IgG against factor VIII)
Same clinical and lab findings (deep joint bleeds and prolonged PTT), but different mixing study
-mixing study (mix pt blood w/ normal plasma): PTT corrects in hemophilia A, PTT does NOT correct in acquired inhibitor (b/c there’s an inhibitor present…)
von Willebrand disease: Lab findings
von Willebrand disease = deficiency in vWF, factor that binds to subendothelial collagen in damaged endothelium and binds plts via receptor Gp1b
Lab findings: prolonged bleeding time (b/c plt activity is impacted), prolonged PTT b/c factor VIII needs vWF to be stable
Abnormal ristocetin test
Ristocetin induces plt agglutination by causing vWF to bind to plt Gp1b (receptor for adhesion).
In vonWillebrand disease, ristocetin won’t cause agglutination (b/c no vWF present) => abnormal test
Explain why the following populations may be deficient in vitamin K
(a) Newborns
(b) Long term abx takers
(c) Malabsorption
(a) Newborns have immature gut flora
- hence why nerborns are prophylactically given vitK injection at birth to prevent hemorrhagic disease of newborn
(b) Long term abx kills the gut flora that normal synthesize vitK
(c) Malabsorption of fat-soluble vitamins (ADEK)
Epoxide reductase function
(a) Effect of inhibition
Epoxide reductase is the liver enzyme that activates vitamin K
(a) When vitK isn’t active, factors X, IX, VII, II, protein C and S don’t get gamma carboxylated => factors aren’t active
What value is followed to monitor effect of liver failure on coagulation
Follow PT: tracks extrinsic pathway (factor VII –> X) and common pathway
- factor VII produced in the liver, so PT is pretty specific
- vs. PTT which counts on factors 12, 11, 9, and 8
What is HIT (heparin induced thrombocytopenia)?
HIT = development of anti-PF-4 (plt factor 4) in response to plt therapy
So plts get destroyed (prolonged bleeding time) and then plt fragments activate remaining plts and cause thrombosis
-so get both bleeding clotting (uhoh)
Tx for heparin induced thrombocytopenia
Tx for HIT (anti-PF4 causing both thrombocytopenia and increased thrombosis)
- Stop the heparin!
- Add an anticoagulant
- DONT use coumadin 2/2 icnreased risk of coumadin necrosis
- first line usually argatroban (direct thrombin inhibitor)
Give some causes of DIC
Disseminated intravascular coagulation: always develops 2/2 something else
- sepsis (especially E. coli or N. meningitidis)
- obstetric complications 2/2 tissue thromboplastin (activates extrinsic coagulation cascade) in amniotic fluid
- adenocarcinoma: mucin activates coagulation
- acute promyelocytic leukemia
- rattlesnake bit: venom activates coagulation
Explain the physiology of DIC and the following lab results
(a) Plt count
(b) PT/PTT
(c) fibrinogen
(d) Hb
DIC = disseminated intravascular coagulation, 2/2 pathologic activation of the coagulation cascade
-then plts consumed => bleeding from skin and mucosal surfaces
(a) Reduced plt count: b/c used up in clots
(b) PT/PTT both elevated b/c coag cascade activated so clotting factors are used up
(c) Fibrinogen decreased b/c used up in clots
(d) Hb reduced b/c intravascular microthrombi causes microangiopathic hemolytic anemia (RBC get sheared in BV as move past clot)
Best screening test for DIC
Best screening test for DIC = D-dimer
D-dimer = fibrin degradation product, so elevated means a mature clot is formed and broken down
Key: D-dimer is produced from splitting of fibrin (stable cross linked clot), NOT from splitting of fibrinogen (weak plt plug not yet undergone secondary hemostasis of coagulation cascade)
Tx for DIC
DIC- it’s not its own entity, need to address the underlying cause
-sepsis, obstetric complication, adenocarcinoma, APL, rattlestnake venom
In the meantime can give supportive care by transfusion of blood products and cryo
Oral agent for tx of vonWillebrand disease
Deficiency in vWF (causing prolonged bleeding time and prolonged PTT) can be tx w/ desmopressin (ADH analogu)
Desmopressin stimulates release of vWF from Weibel-Palade bodies of the endothelial cells
Explain how cirrhosis could disrupt fibrinolysis
Liver produced alpha2-antiplasmin (enzyme that inactivates plasmin, recall plasmin breaks up fibrin in clots)
So w/o alpha2-antitripsin, plasmin remains active breaking up clots => presents similar to DIC
Pt presenting w/ apparent DIC (oozing from IV site, very low plt and fibrinogen serum results), but D-dimer is negative
Dx?
D-dimer is the best screening test for DIC, if D-dimer not positive pt is not in DIC
D/o of fibrinolysis (ex: no aplha2-antitplasmin needed to inactivate plasmin, so plasmin jsut goes around breaking down clots) will present similar to DIC, but coag cascade is not active so no fibrin => no D-dimer
(b/c recall that D-dimer is not produced by breakdown of fibrinogen which is what the immature clots will be in d/o of fibrinolysis)
Name some of the products produced by the endothelium to protect against thrombus formation
- Endothelium blocks collagen exposure
- Produced PGI1 and NO (NO vasodilates)
- Produces tPA to break up clots locally and inactivate coag factors
- Produces heparin-like molecules that augment antithrombin III activity
- Secretes thrombomodulin which modulates thrombin activity so that thrombin activates protein C instead of converting fibrinogen –> fibrin
Thrombomodulin
(a) Secreted by what?
(b) Fxn
Thrombomodulin
(a) Secreted by vascular endothelium
(b) Fxns to change/modulate the fxn of thrombin. So instead of catalyzing fibrinogen–>fibrin (stabilizes clot), thrombin activates protein C (that inactivates factors V and VIII)
Fxn of protein C and S
Both protein C and S inactivate coagulation factors V and VIII
(V involved in common pathway, VIII involved in intrinsic pathway)
Explain why pts are kept on heparin while bridging to warfarin/coumadin therapy
Protein C/S have a shorter half life than factors 1972 => when first started on coumadin therapy there is a short stage of hypercoagulability where protein C/S are deficient but factors 1972 are still present
So keep pt on heparin for that window period where C/S are inactive and 1972 are active
Describe diagnostic finding of ATIII deficiency
Antithrombin III (inactivates thrombin and coagulation factors) increases risk for thrombosis
-especially intravascular b/c ATIII is stimulated/activated by heparin-like molecules produced by endothelium
Diagnostic finding = PTT does not rise in response to heparin
-b/c heparin work by activating ATIII
Antithrombin III
(a) Location of production
(b) Fxn
(c) Key finding of deficiency
ATIII
(a) produced in the liver
(b) Inhibits thrombin and coagulation factors
(c) PTT does not rise in response to heparin b/c heparin works by activating/binding to ATIII
Clinical features of amniotic fluid embolus in mother during labor or delivery
SOB (embolus to lungs), neurologic symptoms (embolus up to brain), DIC (b/c amniotic fluid has a lot of tissue thromboplastin that activates extrinsic pathway of coag cascade)
Based on the components of hemoglobin, name the 4 causes of microcytic anemia
Hb = heme and globin, while heme is iron and protoporphyrin
Reduced iron: (1) iron deficiency anemia (2) anemia of chronic disease
Defective protoporphyrin production (3) sideroblastic anemia
Defective or reduced globin formation (4) thalasesmia
Location of absorption of
(a) Iron
(b) Folate
(a) Iron absorbed in the duodenum by DMT1 transporters, then into blood via ferroportin
(b) Folate absorbed in the jejunum
Why is iron always transported bound to something?
Transported bound to transferrin, stored as ferritin, always bound b/c of Fenton reaction = ability to produce free radicals that cause peroxidation of membranes and oxidation of proteins/DNA
Differentiate bloodwork seen in early iron deficiency vs. uncompensated chronic iron deficiency
Early in iron deficiency anemia there is a normocytic anemia: BM makes normal RBCs just fewer of them. Storage iron gets depleted so ferritin reduces and TIBC increases
Then can no longer compensate and you get microcytic hypochromic anemia: fewer, smaller, lack central pallor
Explain the physiology of anemia of chronic disease
Chronic inflammation => chronic elevation in acute phase reactants from liver including hepcidin
Hepcidin sequesters iron away from bacteria, but also prevents us from using our iron stores => despite high ferritin there is low serum iron and low percent saturation
Name 3 causes of acquired sideroblastic anemia
MC cause is congenital mutation in ALAS (RLS of protoporphyrin synthesis) but 3 acquired causes
- vitamin B6 deficiency (cofactor required for ALAS), can see in isoniazid tx
- alcoholism (mitochondrial poison)
- Pb poisoning (lead denatures two enzymes used after ALAS in protoporphyrin synthesis)
What type of anemia has an elevated serum iron
Serum iron is elevated (above 100) in sideroblastic anemia: b/c iron accessibility isn’t the problem (as it is in iron deficiency or anemia of chrnoic disease), instead there is not enough protoporphyrin for iron to bind to make heme => elevated serum iron and elevated percent saturation
Clinical presentation of 1-4 deletions in alpha globin chain
4 alleles for alpha globin
- 1 deleted = asymptomatic
- 2 deleted = mild anemia w/ elevated RBC count, cis in Asians vs. trans in Africans
- 3 deleted = severe anemia, HbH (beta tetramers)
- 4 deleted = hydrops fetalis lethal in utero, Hb barts (gamma tetramers)
Differentiate cause of alpha and beta thalassemia
Alpha thal due to deletions of 2 to 4 of the alpha globin chains, while beta thal is usually due to mutation of the beta globin gene
So deletion vs. mutation
Differentiate Hb electrophoresis seen in beta thal minor and beta thal major
Beta thal minor: usually asymptomatic w/ increased RBC count
-Slightly decreased HbA w/ increased HbA2 (5% while normal is 2.5%), and HbF (2% while normal is 1%)
Beta thal major: severe anemia starting a few months after birth
-NO HbA, HbA2 (alpha2delta2) and HbF (alpha2gamma2)
Increased risk of parvovirus aplastic crisis
- Beta thal major
- Hereditary spherocytosis
Parvovirus B19 infects erythroid precursors, therefore any disease where it’s hard for pt to tolerate temporary halt in erythropoiesis => increased risk of parvovirus aplastic crisis
Name 2 anemias w/ target cells on peripheral smear
- beta thal minor: see target cell ‘bleb’ due to excess membrane
- Sickle cell: cell continuously sickle and de-sicle thru microcirculation causing reduced cytoplasm => extra membrane causes blebs
Also the two anemias where you get ‘crewcut appearance’ of skull on Xray and ‘chipmunk facies’ due to expansion of hematopoiesis into skull and facial bonesa
Explain how pancreatic insufficiency can cause vit B12 deficiency
Pancreas produces enzyme that cleaves R-binder from B12 so that instrinic factor can bind B12 and aid absorption
In a normocytic anemia how can you differentiate peripheral destruction vs. central underproduction
Reticulocyte count
Retic under 3% suggests poor marrow response = underproduction
While retic count over 3% suggests good marrow response and peripheral destruction
Describe the breakdown of RBC components
Heme –> iron and protoporphyrin
- iron recycled
- protoporphyrin –> unconjugated bilirubin
Globin –> amino acid precursors
Hereditary Spherocytosis
(a) Etiology
(b) Explain the shape of RBCs
(c) What causes the anemia?
HS
(a) Mutation in RBC cytoskeleton-membrane tethering protein
(b) Loss of RBC membrane renders cell spheroid shape (spherocyte) instead of disc shaped
(c) Its not that fewer cells are produced, but the abnormally shaped cells can’t maneuver the splenic sinusoids => RBCs destroyed by splenic macrophages
What is the osmotic fragilty test used to dx?
Osmotic fragilty test- put RBCs in hypotonic solution, normal RBCs have discoid shape that can adapt to a bit of water intake
while spherocytes (seen in hereditary spherocytosis 2/2 defect in RBC cytoskeleton-membrane tethering proteins) have increased fragility in hypotonic solution
Tx for hereditary spherocytosis
Tx is splenectomy- if you remove the spleen there is nothing to remove the oddly shaped RBCs => no more anemia
Mutation in SCD
(a) Mutation in HbC
SIngle amino acid change replaces normal glutamic acid (hydrophilic) w/ valine (hydrophobic) => beta chain of Hb is defective
(a) Hb C due to autosomal recessive mutation of beta chain where normal glutamic acid is replaced by lysin
Differentiate
(a) HbS
(b) HbA
(c) HbA2
(d) HbF
(e) HbH
(f) Hb barts
Hbs
(a) HbS (SCD) = alpha2betaS2
- betaS polymerizes/sickles in hypoxia, acidosis, and dehydration
(b) HbA = adult Hb, alpha2beta2
(c) HbA2 = alpha2delta2
(d) HbF = alpha2gamma2
(e) HbH (seen in alpha thal when 3 of the 4 globin genes are deleted) = beta tetramer
(f) Hb bart (seen in alpha thal when 4 of 4 globin genes are deleted- fetal hydrops) = gamma tetramers
Mechanism of disease in SCD
When both beta globin genes are mutated, 90% of Hb is HbS which polymerizes/sickles w/ hypoxia, dehydration, or acidosis
SCD
(a) Common presenting features in infants
(b) MC cause of death in adults
(a) Dactylitis in child- b/c of vaso-occlusion (causing infarction) in extremities
(b) MC cause of death in adults = acute chest syndrome 2/2 vaso-occlusion in the pulmonary microcirculation